Diffusion tensor imaging of prostate at 3.0 Tesla

Background The feasibility of diffusion tensor imaging (DTI) of prostate has been confirmed by several studies. Apparent diffusion coefficient (ADC) and fractional anisotropy (FA) values of prostate with healthy or pathological changes remain controversial. Purpose To investigate the efficacy of DTI at 3.0 T in diagnosing prostate cancer in the peripheral zone and to determine the normative ADC and FA values of the normal prostate. Material and Methods T2-weighted imaging (T2WI) and DTI of the prostate was performed in 33 cases with diagnosis confirmed by biopsy at 3.0 T MR. ADC and FA values of cancerous and non-cancerous sextants were compared. Receiver-operating characteristic (ROC) curves were used to compare the ability of ADC, FA and the two values combined in diagnosing prostate cancer in the peripheral zone. DTI data of 20 healthy young volunteers were also acquired. ADC and FA values of the normal central gland and the peripheral zone were compared. Results ADC value (1.10 ± 0.09 × 10−3 mm2/s) was lower while FA value (0.37 ± 0.05) was higher in normal central gland, compared with that in normal peripheral zone (1.63 ± 0.15 × 10−3 mm2/s, 0.21 ± 0.07, respectively) (P < 0.0001, P < 0.0001, respectively). Sixteen of 33 cases were confirmed to be malignant while 17 of 33 cases were benign. All the 198 sextants were confirmed by biopsy, including 136 non-cancerous sextants and 62 cancerous sextants. There were significant differences between cancerous sextants (1.02 ± 0.16 × 10−3 mm2/s, 0.38 ± 0.09) and non-cancerous sextants (1.22 ± 0.14 × 10−3 mm2/s, 0.31 ± 0.06) for both ADC and FA values (P <0.0001, P <0.0001, respectively). Significant differences were noted between the AUC of DTI and FA alone (0.86 vs. 0.76, P = 0.0009), but no differences between the AUC of DTI and ADC alone (0.86 vs. 0.84, P = 0.1595). Conclusion ADC and FA values of normal prostate may be compatible with the microstructural organization of prostate. Furthermore, DTI may be a potential tool in diagnosing prostate cancer in the peripheral zone.

[1]  A. Padhani,et al.  Reproducibility of quantitative dynamic MRI of normal human tissues , 2002, NMR in biomedicine.

[2]  N M deSouza,et al.  Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer. , 2008, Clinical radiology.

[3]  S. Furui,et al.  Clinical efficacy of proton magnetic resonance spectroscopy (1H-MRS) in the diagnosis of localized prostate cancer. , 2008, Anticancer research.

[4]  Guglielmo Manenti,et al.  Diffusion Tensor Magnetic Resonance Imaging of Prostate Cancer , 2007, Investigative radiology.

[5]  D P Dearnaley,et al.  Dynamic contrast enhanced MRI of prostate cancer: correlation with morphology and tumour stage, histological grade and PSA. , 2000, Clinical radiology.

[6]  Riwa Kishimoto,et al.  ADC value and diffusion tensor imaging of prostate cancer: Changes in carbon‐ion radiotherapy , 2008, Journal of magnetic resonance imaging : JMRI.

[7]  Usha Sinha,et al.  In vivo diffusion tensor imaging of the human prostate , 2004, Magnetic resonance in medicine.

[8]  Byung Kwan Park,et al.  Value of Diffusion-Weighted Imaging for the Prediction of Prostate Cancer Location at 3T Using a Phased-Array Coil: Preliminary Results , 2007, Investigative radiology.

[9]  L. Turnbull,et al.  Diffusion Imaging of the Prostate at 3.0 Tesla , 2006, Investigative radiology.

[10]  J. Kurhanewicz,et al.  Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer , 2002, Journal of magnetic resonance imaging : JMRI.

[11]  A. Jemal,et al.  Cancer Statistics, 2007 , 2007, CA: a cancer journal for clinicians.

[12]  A. Uluğ,et al.  Diffusion tensor imaging of the normal prostate at 3 Tesla , 2007, European Radiology.

[13]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[14]  Junqian Xu,et al.  Magnetic resonance diffusion characteristics of histologically defined prostate cancer in humans , 2009, Magnetic resonance in medicine.

[15]  D. Regge,et al.  Value of endorectal MRI and MRS in patients with elevated prostate-specific antigen levels and previous negative biopsies to localize peripheral zone tumours. , 2008, Clinical radiology.

[16]  P. Basser,et al.  Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. , 1996, Journal of magnetic resonance. Series B.